[Antimycotic therapy on intensive care units: pro].
Füssle
R
R
Institut für Medizinische Mikrobiologie, Justus-Liebig-Universität Giessen.
Boldt
J
J
D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy / Q000401:mortality / Q000635:transmission; D002408:Catheters, Indwelling; D003428:Cross Infection / Q000188:drug therapy* / Q000401:mortality / Q000635:transmission; D006801:Humans; D007362:Intensive Care Units; D009181:Mycoses / Q000188:drug therapy* / Q000401:mortality / Q000635:transmission; D009894:Opportunistic Infections / Q000188:drug therapy / Q000401:mortality / Q000635:transmission; D012307:Risk Factors
D000935:Antifungal Agents
Antimykotische Therapie auf Intensivstationen: Pro.